Cholibrium

Cholibrium sells a single flagship dietary supplement—marketed as a “heart health blend” of omega-3-rich algal oil, plant sterols, CoQ10 and citrus bergamot—offered only in 60-capsule bottles. Price sits at the premium end of the cardiovascular-supplement aisle: USD 59 per bottle or USD 178 for a three-month subscription. All sales flow through the brand’s own Shopify site; no Amazon, pharmacy or retail presence is listed. The capsule is pitched as the first “cardiologist-formulated, algae-based” alternative to fish-oil pills that also delivers clinically studied doses of sterols and bergamot in one vegan soft-gel. Cholibrium leans on third-party purity testing, a USP-verified algal source and carbon-neutral packaging to position itself as a clean, sustainable heart-care option. Core buyers are 40-65-year-old professionals with borderline cholesterol or elevated triglycerides who want evidence-backed support without fish burps or animal products. The brand appeals to sustainability-minded consumers who value vegan credentials, subscription convenience and transparent COA documentation over bargain pricing. Cholibrium competes in the fast-growing “clean cardio” niche against both premium fish-oil leaders and condition-specific blends; it differentiates by replacing marine oil entirely with algae, stacking multiple cardio actives in one pill, and keeping the entire supply chain DTC to control freshness and storytelling.